10-Bromodecanoic acid

10-Bromodecanoic acid Property

Melting point:

38-41 °C (lit.)

Boiling point:

160 °C(Press: 1 Torr)

Density 

1.3099 (rough estimate)

refractive index 

1.5845 (estimate)

Flash point:

>231 °F

storage temp. 

Keep in dark place,Sealed in dry,Room Temperature

form 

powder to crystal

pka

4.78±0.10(Predicted)

color 

White to Light yellow to Light orange

Water Solubility 

Partly miscible in water.

CAS DataBase Reference

50530-12-6(CAS DataBase Reference)

NIST Chemistry Reference

10-Bromodecanoic acid(50530-12-6)

Safety

Hazard Codes 

Xi

Risk Statements 

36/37/38

Safety Statements 

26-37

WGK Germany 

3

HazardClass 

IRRITANT

HS Code 

29159000

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Warning

Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P405Store locked up.

10-Bromodecanoic acid Chemical Properties,Usage,Production

Chemical Properties

Flaky crystals. Melting point 42°C, boiling point 163-165°C (0.27 kPa).

Uses

10-Bromodecanoic acid may be employed as an alkylcarboxylate chain source in the preparation of alkylcarboxylate-grafted polyethylenimine. It may also be used in the synthesis of :

• 10-(methylsulfinyl)decanoic acid
• 10-cyanodecanoic acid
• (10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)-decyl)triphenylphosphonium bromide
• 11-thiastearic acid

General Description

10-Bromodecanoic acid can be prepared from 10-bromodecanol via oxidation.

reaction suitability

reagent type: linker

Synthesis

The general procedure for the synthesis of 10-bromodecanoic acid from 10-bromo-1-decanol is as follows: 1. 48% hydrobromic acid (22.6 mL, 0.2 mol, 1 eq.) was slowly added dropwise to a toluene solution (400 mL) of 1,10-decanediol (34.8 g, 0.2 mol, 1 eq.) with stirring and refluxed for 24 hr. at 180° C. using a Dean-Stark manifold. 2. After completion of the reaction, the mixture was cooled to room temperature and washed sequentially with 6N NaOH (150 mL), 10% HCl (150 mL), water (2 x 250 mL) and brine (200 mL). 3. The organic layer was dried over anhydrous sodium sulfate and concentrated, separated by silica gel column chromatography using cyclohexane/ethyl acetate (4:1) as eluent to afford 43.5 g (92%) of 10-bromo-1-decanol as a colorless liquid. 4. To an acetone solution (130 mL) of 10-bromo-1-decanol (41 g, 0.17 mol, 1 eq.) was slowly added a chromic acid solution prepared from chromium trioxide (25.7 g, 0.26 mol, 1.5 eq.), water (25 mL), and concentrated sulfuric acid (22.5 mL, 0.34 mol, 2 eq.) at -5°C. 5. The reaction mixture was stirred at 0°C for 2 hours and then left at room temperature overnight. 6. After completion of the reaction, the mixture was extracted with ether (3 x 250 mL), washed sequentially with water (250 mL) and brine (250 mL), dried over anhydrous sodium sulfate and concentrated. 7. The residue was separated by silica gel column chromatography using dichloromethane as eluent and recrystallized from petroleum ether to give 31.0 g (73%) of 10-bromodecanoic acid as a white solid with a melting point of 36-37 °C. The residue was separated by 1H2O2 column chromatography using dichloromethane as eluent. 8. The structure of the product was confirmed by 1H NMR and 13C NMR: 1H NMR δ 11.23 (bs, 1H, -OH), 3.41 (t, J = 7.0 Hz, 2H, H-10), 2.36 (t, J = 7.6 Hz, 2H, H-2), 1.87 (m, 2H, H-9), 1.64 (m, 2H, H-3), 1.22- 1.44 (m, 10H, H-3), 1.22- 2H, H-3). 1.44 (m, 10H, H-4-8); 13C NMR δ 180.2 (C1), 34.1 (C2), 34.0 (C10), 32.9, 29.1, 28.9, 28.6, 28.4, 28.2, 24.7.

References

[1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 1, p. 567 - 579
[2] Patent: DE867243, 1943,
[3] Journal of the American Chemical Society, 1956, vol. 78, p. 2255,2256
[4] Journal of Organic Chemistry, 1956, vol. 21, p. 883,885
[5] Molecular Crystals and Liquid Crystals Science and Technology, Section A: Molecular Crystals and Liquid Crystals, 2000, vol. 350, p. 93 - 101